Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial
Countries citing papers authored by David C. Smith
Since
Specialization
Citations
This map shows the geographic impact of David C. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David C. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David C. Smith more than expected).
This network shows the impact of papers produced by David C. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David C. Smith. The network helps show where David C. Smith may publish in the future.
Co-authorship network of co-authors of David C. Smith
This figure shows the co-authorship network connecting the top 25 collaborators of David C. Smith.
A scholar is included among the top collaborators of David C. Smith based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with David C. Smith. David C. Smith is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Rosenberg, Jonathan E., Srikala S. Sridhar, Jingsong Zhang, et al.. (2020). EV-101: A Phase I Study of Single-Agent Enfortumab Vedotin in Patients With Nectin-4–Positive Solid Tumors, Including Metastatic Urothelial Carcinoma. Journal of Clinical Oncology. 38(10). 1041–1049.223 indexed citations breakdown →
Smith, David C., et al.. (2007). Thomas Hickey, the Rebel, and Civil Liberties in Wartime Texas. Index of Texas Archaeology Open Access Grey Literature from the Lone Star State. 45(1). 12.
Litoff, Judy Barrett & David C. Smith. (1997). American Women in a World at War: Contemporary Accounts from World War II. Bryant Digital Repository (Bryant University).3 indexed citations
12.
Smith, David C.. (1996). Surgery: it's not a random therapy.. PubMed. 12(3). 19–38.1 indexed citations
13.
Litoff, Judy Barrett & David C. Smith. (1994). We're In This War Too: World War II Letters from American Women in Uniform. Bryant Digital Repository (Bryant University).2 indexed citations
14.
Smith, David C.. (1990). Accreditation of Teacher Education Institutions: An Interview with Richard Kunkel.. Journal of Teacher Education. 41(4). 3–6.
15.
Smith, David C., et al.. (1988). TENS for post-surgical analgesia following gastroplasty.. PubMed. 78(8). 369–71.4 indexed citations
16.
Smith, David C., et al.. (1988). Some characteristics of glass ionomer cement lining materials.. PubMed. 54(12). 903–8.10 indexed citations
17.
Smith, David C., et al.. (1987). Towards a selective policy of operative cholangiography: a prospective clinical study.. PubMed. 32(1). 15–8.4 indexed citations
18.
Smith, David C.. (1986). A historical overview of the recognition of appendicitis--Part I.. PubMed. 86(11). 571–47.5 indexed citations
19.
Smith, David C.. (1984). PROTEACH: Professional Teacher Preparation at the University of Florida.. Phi Delta Kappan. 66(2).3 indexed citations
20.
Smith, David C.. (1972). Professional Negotiations and the Principal..
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.